OTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
Topcare Allergy Relief 180 mg tablets recalled for failed impurity and degradation specifications. The recall affects 44,280 cartons distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. This is a manufacturing quality control failure addressed through precautionary recall; the absence of reported adverse events and unspecified impurity details place this in the Moderate category.
Plain-English summary
Topcare Allergy Relief 180 mg fexofenadine hydrochloride tablets are being recalled due to failed manufacturing specifications for impurities and product degradation. The product is manufactured by L. Perrigo Company and distributed by Topco Associates LLC.
The recall affects 44,280 cartons distributed nationwide. Specific lot numbers include 2FV1948, 2ER0285, 2ER0411, 2CR0653, and 2GR0331, with varying expiration dates from December 2023 through April 2024.
Consumers who have purchased this medication should discontinue use and contact their healthcare provider or pharmacist with questions. Check medicine cabinets for the affected lot numbers and expiration dates.
The recalled product
- Product
- TOPCARE ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)
- Brand
- TOPCARE ALLERGY RELIEF
- Manufacturer
- L. Perrigo Company
- Hazard
- impurity
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: a) 2FV1948
- 2ER0285
- 2ER0411
- Exp. Date 01/24 b)2CR0653
- Exp. Date 12/23 c)2GR0331
- Exp. Date 04/24
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27